Digestive System Cancer

3

Review clinical trials related to Digestive System Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Target-specific immunoPET Imaging of Digestive System Carcinoma

The aim of this study is to establish and optimize the target-specific PET/CT imaging method, and its physiological and pathological distribution characteristics, on the basis of which the diagnostic efficacy of the above imaging agents in digestive system malignant tumors will be evaluated.

Participants needed: 400
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: RenJi HospitalUpdated: Dec 31, 2025Locations: 1
Eligibility criteria

Aged 18-75 years old and of either sex; [+2]

Pregnancy; [+3]

Status: Recruiting

Real-World Study on Nano-Crystalline Megestrol Acetate for Cachexia in TKI-Treated Advanced Digestive Tumors

This study is a prospective, observational clinical study aimed at evaluating the efficacy of Megestrol Acetate for cachexia in patients with advanced digestive system tumors receiving TKI-based therapy.

Participants needed: 120
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Changchun GeneScience Pharmaceutical Co., Ltd.Updated: Apr 23, 2025Locations: 2
Eligibility criteria

Voluntarily sign a written informed consent (ICF). [+7]

Gastrointestinal obstruction. [+5]

Status: Recruiting

Nutritional Psychological Intervention and Vomit-free Management on Survival and Quality of Life in Advanced Gastrointestinal Tumors

Aims to observe and evaluate the impact of survival and quality of life of patients with gastrointestinal tumors such as advanced esophageal, gastric, liver, pancreatic, and colorectal cancers through nutritional-psychological interventions versus no-vomit management compared to standard antitumor therapy alone

Participants needed: 316
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Renmin Hospital of Wuhan UniversityUpdated: Jan 30, 2024Locations: 1
Eligibility criteria

Age 18-75, male or female; [+5]

Other malignant tumors diagnosed within the previous 5 years, except for effecti... [+5]